ARTERY intends to start a robotic revolution in structural heart surgery, paving the way to the scenario we envisage in ten years from now. SHD percutaneous treatments will be performed by autonomous robots, with minimal mental effort for the doctor; human-robot interaction will be intuitive, with maximum safety for both doctors and patients. These features will set a new gold standard in percutaneous treatment, offering a safe and reliable outcome and making open heart surgery a treatment of the past.

To achieve this objective, ARTERY will pursue six technological objectives:

Funded by the European Union under the Horizon 2020 Research and Innovation Programme, ARTERY is an initiative led at international level in 4 different countries: Italy, Belgium, Germany and Switzerland. The 7 scientific and technical partners involved are: Politecnico di Milano (coordinator), in cooperation with Fondazione Politecnico di Milano, Artiness, FBGS, IRCCS San Raffaele Hospital, KU Leuven, Scuola Superiore Sant’Anna, SwissVortex. The project will last 3 years, from January 2021 to September 2024.



The project started in January 2021 and will come to a conclusion in September 2024